Relevance of hitdisc-20261022-protocol-kim-sigma2 to use-case-hit-discovery-virtual-screening
- Use case
- Find hits for a target by virtual screening
- Assessed by
- Re-ranking the Sigma-2 receptor docking hit list by co-folding and docking scores (Kim, Correy, Hall et al. 2026)
- Relevance
- Direct evidence
- Endpoint
- Area under the ROC curve for separating measured binders from high-ranking docking false positives, printed on a 0-100 scale
Relevance judgement drafted by the extraction agent. Not reviewed.
3 reviewed evaluations
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
19 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
Citation locations1 values
| Kim, Correy, Hall et al. 2026, eLife 15:RP110475 (Europe PMC full text) hitdisc-20261022-protocol-kim-sigma2: see its source_locator Version: PMC13657626 (eLife 2026;15:RP110475, version of record published 2026-10-12) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Comparison group prospective-tested-hit-lists Context-only references | Kim, Correy, Hall et al. 2026, eLife 15:RP110475 (Europe PMC full text) hitdisc-20261022-protocol-kim-sigma2: see its source_locator Version: PMC13657626 (eLife 2026;15:RP110475, version of record published 2026-10-12) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Comparison title Re-ranking compounds that were synthesised and assayed Context-only references | Kim, Correy, Hall et al. 2026, eLife 15:RP110475 (Europe PMC full text) hitdisc-20261022-protocol-kim-sigma2: see its source_locator Version: PMC13657626 (eLife 2026;15:RP110475, version of record published 2026-10-12) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Constraints3 values
| Kim, Correy, Hall et al. 2026, eLife 15:RP110475 (Europe PMC full text) hitdisc-20261022-protocol-kim-sigma2: see its source_locator Version: PMC13657626 (eLife 2026;15:RP110475, version of record published 2026-10-12) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Endpoint Area under the ROC curve for separating measured binders from high-ranking docking false positives, printed on a 0-100 scale Context-only references | Kim, Correy, Hall et al. 2026, eLife 15:RP110475 (Europe PMC full text) hitdisc-20261022-protocol-kim-sigma2: see its source_locator Version: PMC13657626 (eLife 2026;15:RP110475, version of record published 2026-10-12) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Claimed field links:assessed_by:hitdisc-20261022-protocol-kim-sigma2 Context-only references | Kim, Correy, Hall et al. 2026, eLife 15:RP110475 (Europe PMC full text) hitdisc-20261022-protocol-kim-sigma2: see its source_locator Version: PMC13657626 (eLife 2026;15:RP110475, version of record published 2026-10-12) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Headline metric auroc Context-only references | Kim, Correy, Hall et al. 2026, eLife 15:RP110475 (Europe PMC full text) hitdisc-20261022-protocol-kim-sigma2: see its source_locator Version: PMC13657626 (eLife 2026;15:RP110475, version of record published 2026-10-12) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Limitations5 values
| Kim, Correy, Hall et al. 2026, eLife 15:RP110475 (Europe PMC full text) hitdisc-20261022-protocol-kim-sigma2: see its source_locator Version: PMC13657626 (eLife 2026;15:RP110475, version of record published 2026-10-12) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Pinned records9 values
| Kim, Correy, Hall et al. 2026, eLife 15:RP110475 (Europe PMC full text) hitdisc-20261022-protocol-kim-sigma2: see its source_locator Version: PMC13657626 (eLife 2026;15:RP110475, version of record published 2026-10-12) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Rationale Direct: every compound in the list was synthesised and assayed, the labels are measured potencies with a stated threshold, the negatives are the false positives a real ultra-large docking screen produced, and DOCK3.7, the engine that produced the list, is scored on the same compounds. This is the use case's question asked on the hardest realistic negatives. Boltz-2 pIC50 separates binders best here (AUC 83.8), ahead of DOCK3.7 (78.8), while AF3 L-pLDDT is close to uninformative (56.1). Context-only references | Kim, Correy, Hall et al. 2026, eLife 15:RP110475 (Europe PMC full text) hitdisc-20261022-protocol-kim-sigma2: see its source_locator Version: PMC13657626 (eLife 2026;15:RP110475, version of record published 2026-10-12) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-10-22-1b7cf027e4f6 · Record review: source checked
1 source record and release history
- Kim, Correy, Hall et al. 2026, eLife 15:RP110475 (Europe PMC full text) · Original source · PMC13657626 (eLife 2026;15:RP110475, version of record published 2026-10-12)
Technical metadata and extraction receipts
Stable ID: hitdisc-20261022-use-case-mapping-kim-sigma2
- field
- links:assessed_by:hitdisc-20261022-protocol-kim-sigma2
- value
- hitdisc-20261022-protocol-kim-sigma2
- relevance
- direct
- endpoint
- Area under the ROC curve for separating measured binders from high-ranking docking false positives, printed on a 0-100 scale
- rationale
- Direct: every compound in the list was synthesised and assayed, the labels are measured potencies with a stated threshold, the negatives are the false positives a real ultra-large docking screen produced, and DOCK3.7, the engine that produced the list, is scored on the same compounds. This is the use case's question asked on the hardest realistic negatives. Boltz-2 pIC50 separates binders best here (AUC 83.8), ahead of DOCK3.7 (78.8), while AF3 L-pLDDT is close to uninformative (56.1).
- constraints
- Inspect every linked evaluation's source locator before citing a result.; Compare rows only within this protocol. Enrichment factors from different protocols are not comparable, because the actives-to-inactives ratio and the construction of the negatives differ.; Do not read a result from this protocol together with the Mac1 pose results or the CASF-2016 scoring, ranking and docking protocols already in this store: those measure pose and scoring accuracy, not the ranking of a library.
- limitations
- Only high-ranking docked molecules were synthesised, so the list is a biased sample of the 490-million library and no value from it estimates performance over a whole library.; The comparison is a retrospective re-ranking of a prospectively tested set, not a new prospective screen.; No training-overlap control is stated for this arm.; Transcribed from the source; no reproduction by Rewire and no human scientific review.; No ligand-similarity or pharmacophore baseline is scored on any protocol in this batch, although issue #177 asks for one as the pre-machine-learning comparator alongside docking.
- citation locators
- source id: hitdisc-20261022-source-kim2026; locator: See the protocol record's source_locator
- source locator
- hitdisc-20261022-protocol-kim-sigma2: see its source_locator
- headline metric
- auroc
- comparison group
- prospective-tested-hit-lists
- comparison title
- Re-ranking compounds that were synthesised and assayed
- stratum label
- Sigma-2 receptor: 201 binders and 305 docking false positives
- stratum order
- 1
- reason
- Hit-discovery use-case pass 2026-10-22: relevance of a protocol to a new use case (rewire-benchmark-data #177).
- review
- method: scope-review; automated-source-review; reviewer: claude; reviewer note: Claude review agent, independent of the extraction agent; no human review claimed; date: 2026-10-22; method note: Read the record against the pinned sources and against docs/use-cases.md and docs/record-contract.md.; note: Claim checked against the pinned source. Every figure it states was matched to a result record in this batch.; artifact sha256: 9be510b7b0cc152ff56a03c96877bf06b6a6bdeffdb4baecf8e999a6bf155aa6; retrieval url: https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13657626/fullTextXML; receipt: data/omics/use-case-coverage-hitdisc-20261022/review.json
- reviewed evaluations
- hitdisc-20261022-eval-kim-sigma2-kim-af3-lplddt; hitdisc-20261022-eval-kim-sigma2-kim-boltz2-pic50; hitdisc-20261022-eval-kim-sigma2-kim-dock37
- pins
- record id: hitdisc-20261022-eval-kim-sigma2-kim-af3-lplddt; fields: status; links; attributes.origin; attributes.comparison; sha256: 54d7ea57dfb714244dc9b4c54ed0e460b1fd6ba590bed3e06424b70b34025792; record id: hitdisc-20261022-eval-kim-sigma2-kim-boltz2-pic50; fields: status; links; attributes.origin; attributes.comparison; sha256: e1625e6e2a69b15b6c286391f7bbe65d1c74192ac08744b1893a3316d48c5aa1; record id: hitdisc-20261022-eval-kim-sigma2-kim-dock37; fields: status; links; attributes.origin; attributes.comparison; sha256: 072bcdbc3297eac35d074e238ecab85cf052b5c8c4801a1b25eb1bbfc79d82a9; record id: hitdisc-20261022-protocol-kim-sigma2; fields: status; name; description; facets; source_ids; links; attributes; sha256: 7ee7da38ae50226ea990ccbe0210662d41c6ad281fce5159dc412bf4871cf396; record id: hitdisc-20261022-result-kim-sigma2-kim-af3-lplddt-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 3be2005e38657ec62af9002c5b3b87c068b629119904648a1fa2435d9ef1edcd; record id: hitdisc-20261022-result-kim-sigma2-kim-boltz2-pic50-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: a0b919ba6e97f34ab0d05a554db357f1135dc31df324e982b94e7129cdb2802b; record id: hitdisc-20261022-result-kim-sigma2-kim-dock37-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 169e32efa2b3363e47997168725bfe75609514573424f287da77856d40ebbb12; record id: hitdisc-20261022-source-kim2026; fields: status; attributes.artifact_sha256; sha256: 8c250400b9ac77a8c25aa8ff203ea04473f5b3c98eeb1c49cb499d0a26b92a10; record id: use-case-hit-discovery-virtual-screening; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: dc57177bbc7bd26bcb01b194ecc3598e987ff5dc02a07432c4585abfde8e97cc